{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T18:26:37Z","timestamp":1648578397721},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med","J. Jpn. Soc. Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/naika.103.2440","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T22:03:09Z","timestamp":1444428189000},"page":"2440-2448","source":"Crossref","is-referenced-by-count":3,"title":["2. Allied Conditions, 2) Polymyalgia Rheumatica"],"prefix":"10.2169","volume":"103","author":[{"given":"Koji","family":"Nishioka","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Clinical Application of Biologics, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Lawrence RC, et al: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58: 26-35, 2008.","DOI":"10.1002\/art.23176"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kreiner F, et al: Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatic. Arthritis Rheum 62: 3768-3775, 2010.","DOI":"10.1002\/art.27728"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Salvarani C, et al: Polymyalgia rheumatica and giant-cell arteritis. Lancet 372: 234-245, 2008.","DOI":"10.1016\/S0140-6736(08)61077-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Straub RH, et al: The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology (Oxford) 39: 624-631, 2000.","DOI":"10.1093\/rheumatology\/39.6.624"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Cantini F, et al: Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum 30: 17-24, 2000.","DOI":"10.1053\/sarh.2000.8366"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Dasgupta B, et al: 2012 Provisional classification criteria for polymyalgia rheumatica:a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rhuem Dis 71: 484-492, 2012.","DOI":"10.1016\/j.ymed.2012.09.009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8) Michet CJ, Matteson EL: Polymyalgia rheumatica. BMJ 336: 765-769, 2008.","DOI":"10.1136\/bmj.39514.653588.80"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Muller S, et al: Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database. Ann Rheum Dis 73: 1769-1773, 2014.","DOI":"10.1136\/annrheumdis-2013-203465"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) Dasgupta B, et al: BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford) 49: 186-190, 2010.","DOI":"10.1093\/rheumatology\/kep303a"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11) Leeb BF, et al: The polymyalgia rheumatica activity score in daily use:proposal for a definition of remission. Arthritis Rheum 57: 810-815, 2007.","DOI":"10.1002\/art.22771"},{"key":"11","doi-asserted-by":"crossref","unstructured":"13) Mori S, Koga Y: Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy. Clin Rheumatol 2014 May 8. [Epub ahead of print] DOI 10.1007\/s10067-014-2650-y","DOI":"10.1007\/s10067-014-2650-y"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":["2\uff0e\u985e\u7e01\u75be\u60a3\u30002\uff09\u30ea\u30a6\u30de\u30c1\u6027\u591a\u767a\u7b4b\u75db\u75c7"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/103\/10\/103_2440\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T10:47:51Z","timestamp":1567248471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/103\/10\/103_2440\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.103.2440","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}